Cited 0 time in
Response to Xu, Lou, and Xu
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chen, Qiao-Yi | - |
| dc.contributor.author | Keum, Nana | - |
| dc.contributor.author | Giovannucci, Edward L. | - |
| dc.date.accessioned | 2025-08-18T07:00:08Z | - |
| dc.date.available | 2025-08-18T07:00:08Z | - |
| dc.date.issued | 2025-11 | - |
| dc.identifier.issn | 0027-8874 | - |
| dc.identifier.issn | 1460-2105 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/58967 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.format.extent | 2 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Oxford University Press | - |
| dc.title | Response to Xu, Lou, and Xu | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1093/jnci/djaf169 | - |
| dc.identifier.scopusid | 2-s2.0-105021245162 | - |
| dc.identifier.wosid | 001543339700001 | - |
| dc.identifier.bibliographicCitation | JNCI: Journal of the National Cancer Institute, v.117, no.11, pp 2403 - 2404 | - |
| dc.citation.title | JNCI: Journal of the National Cancer Institute | - |
| dc.citation.volume | 117 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 2403 | - |
| dc.citation.endPage | 2404 | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
